[Comparison of the anticonvulsant and central effects of 3-bromophenylsuccinimide and N-methylimide of 3,5-dibromophenylsuccinic acid].
D000818:Animals; D000927:Anticonvulsants / Q000494:pharmacology*; D001640:Bicuculline / Q000009:adverse effects / Q000037:antagonists & inhibitors; D001974:Bromosuccinimide / Q000494:pharmacology*; D003864:Depression, Chemical; D005260:Female; D006801:Humans; D006993:Hypnotics and Sedatives / Q000494:pharmacology*; D051379:Mice; D009043:Motor Activity / Q000187:drug effects*; D010433:Pentylenetetrazole / Q000009:adverse effects / Q000037:antagonists & inhibitors; D012640:Seizures / Q000139:chemically induced / Q000188:drug therapy*; D013239:Stereotyped Behavior / Q000187:drug effects*; D013388:Succinimides / Q000494:pharmacology* / Q000627:therapeutic use
D000927:Anticonvulsants; D006993:Hypnotics and Sedatives; D013388:Succinimides; C002318:3-bromophenylsuccinimide; C037891:3,5-dibromophenylsuccinic acid N-methylimide; D001974:Bromosuccinimide; D010433:Pentylenetetrazole; D001640:Bicuculline
Porównanie przeciwdrgawkowego i ośrodkowego działania imidu kwasu 3-bromofenylobursztynowego i n-metyloimidu kwasu 3,5-dwubromofenylobursztynowego.